Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v3.10.0.1
Licenses Acquired (Tables)
 9 Months Ended
Sep. 30, 2018
Research and Development Arrangement, Contract to Perform for Others As such, for the three and nine months ended September 30, 2018 and 2017, the purchase price of licenses acquired was classified as research and development-licenses acquired in the Condensed Consolidated Statements of Operations, as reflected in the table below:
 
 
 
For the Three Months Ended September 30,
 
 
For the Nine Months Ended September 30,
 
($ in thousands)
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Fortress
 
$
–
 
 
$
–
 
 
$
–
 
 
$
300
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fortress Companies:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Checkpoint
 
 
1,000
 
 
 
–
 
 
 
1,000
 
 
 
400
 
Helocyte
 
 
1,500
 
 
 
–
 
 
 
1,521
 
 
 
–
 
Mustang
 
 
1,000
 
 
 
300
 
 
 
1,075
 
 
 
2,375
 
Cellvation
 
 
–
 
 
 
–
 
 
 
1
 
 
 
–
 
Caelum
 
 
201
 
 
 
–
 
 
 
201
 
 
 
219
 
Cyprium
 
 
–
 
 
 
–
 
 
 
–
 
 
 
100
 
Aevitas
 
 
5
 
 
 
–
 
 
 
6
 
 
 
–
 
Total
 
$
3,706
 
 
$
300
 
 
$
3,804
 
 
$
3,394
 
Schedule of Licenses Acquired Expenses [Table Text Block]
The table below provides a summary of Checkpoint’s expense related to its licenses, for the three and nine months ended September 30, 2018 and 2017 by license as recorded in the Condensed Consolidated Statements of Operations:
 
 
 
For the Three Months Ended September 30,
 
 
For the Nine Months Ended September 30,
 
($ in thousands)
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Dana Farber License CK-301
 
$
1,000
 
 
$
–
 
 
$
1,000
 
 
$
–
 
Jubilant Biosys License CK-103
 
 
–
 
 
 
–
 
 
 
–
 
 
 
400
 
Total Licenses Acquired Expense
 
$
1,000
 
 
$
–
 
 
$
1,000
 
 
$
400
 
 
The table below provides a summary of Mustang’s expense related to its licenses, for the three and nine months ended September 30, 2018 and 2017 by license as recorded in the Condensed Consolidated Statements of Operations:
 
 
 
For the Three Months Ended September 30,
 
 
For the Nine Months Ended September 30,
 
($ in thousands)
 
2018
 
 
2017
 
 
2018
 
 
2017
 
City of Hope (COH) IL-13 License
 
$
–
 
 
$
–
 
 
$
–
 
 
$
250
 
COH IV/ICV License
 
 
–
 
 
 
–
 
 
 
–
 
 
 
125
 
COH HER2 License
 
 
–
 
 
 
–
 
 
 
–
 
 
 
600
 
COH CS-1 License
 
 
–
 
 
 
–
 
 
 
–
 
 
 
600
 
COH License for PSCA
 
 
–
 
 
 
–
 
 
 
–
 
 
 
300
 
UCLA License for PSCA
 
 
–
 
 
 
–
 
 
 
–
 
 
 
 200
 
Fred Hutch CD20
 
 
–
 
 
 
 300
 
 
 
–
 
 
 
300
 
X-SCID License – St. Jude’s
 
 
1,000
 
 
 
–
 
 
 
1,000
 
 
 
–
 
Manufacturing License
 
 
–
 
 
 
–
 
 
 
75
 
 
 
–
 
Total licenses acquired expense
 
$
1,000
 
 
$
300
 
 
$
1,075
 
 
$
2,375